Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	1282115.32	-123.76	< 0.005
Graham Fair Price	41.43	0.09	0.07
PEG	-54.12	< 0.005	0.02
Price/Book	< 0.005	1.82	1.82
Price/Cash Flow	< 0.005	1.75	1.75
Prices/Earnings	50.00	-0.70	-1.39
Price/Sales	-84.48	5360.26	34546.41
Price/FCF	< 0.005	1.75	1.75
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-84.48	0.16	1.00
Operating Margin	69.01	-241.38	-778.78
ROA	-100.00	-0.04	-0.02
ROE	-0.33	-0.65	-100.00
ROIC	< 0.005	< 0.005	19.71
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.96	-1.00	49.04
EPS QOQ	0.92	-1.00	8.97
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	1.00	5.44	444.43
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	2643215.51	100.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	< 0.005	100.00
Debt/Capitalization	0.00	0.91	100.00
Quick Ratio	25.81	26.09	1.06
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.02	0.02	< 0.005
Cash	0.04	0.04	1.07
Capex	0.00	0.00	0.00
Free Cash Flow	0.03	0.03	< 0.005
Revenue	< 0.005	< 0.005	544.49
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	25.81	25.81	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.39	-101.52	1488.45
Naive Interpretation	Member

06 - Financial Health · Bad

Rating